Atlas Trials

Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor

Clinical trial NCT02069080 · TERMINATED

Trial details

NCT number
NCT02069080
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2014-02-20
Primary completion
2018-07-10
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.